IKBKG
NF-kappa-B essential modulator
Also known as: FIP-3, FIP3, Fip3p, IKK-gamma, IKKAP1, IKKG, IP1, IP2, NEMO, NEMO_HUMAN, ZC2HC9
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y6K9
- Gene
- IKBKG
- Ensembl
- ENSG00000269335
- Chromosome
- X
- Canonical length
- 419 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes the regulatory subunit of the inhibitor of kappaB kinase (IKK) complex, which activates NF-kappaB resulting in activation of genes involved in inflammation, immunity, cell survival, and other pathways. Mutations in this gene result in incontinentia pigmenti, hypohidrotic ectodermal dysplasia, and several other types of immunodeficiencies. A pseudogene highly similar to this locus is located in an adjacent region of the X chromosome. [provided by RefSeq, Mar 2016]
Canonical amino-acid sequenceUniProt
419 residues, UniProt reviewed canonical sequence.
>Q9Y6K9|IKBKG
1 MNRHLWKSQL CEMVQPSGGP AADQDVLGEE SPLGKPAMLH LPSEQGAPET LQRCLEENQE
61 LRDAIRQSNQ ILRERCEELL HFQASQREEK EFLMCKFQEA RKLVERLGLE KLDLKRQKEQ
121 ALREVEHLKR CQQQMAEDKA SVKAQVTSLL GELQESQSRL EAATKECQAL EGRARAASEQ
181 ARQLESEREA LQQQHSVQVD QLRMQGQSVE AALRMERQAA SEEKRKLAQL QVAYHQLFQE
241 YDNHIKSSVV GSERKRGMQL EDLKQQLQQA EEALVAKQEV IDKLKEEAEQ HKIVMETVPV
301 LKAQADIYKA DFQAERQARE KLAEKKELLQ EQLEQLQREY SKLKASCQES ARIEDMRKRH
361 VEVSQAPLPP APAYLSSPLA LPSQRRSPPE EPPDFCCPKC QYQAPDMDTL QIHVMECIELocalizationUniProt · AlphaFold · HPA
Whether an antibody against IKBKG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 63 nTPM
Expression across tissuesHPA
Tissue
- liver: 63 nTPM
- spleen: 43 nTPM
- adrenal gland: 29 nTPM
- bone marrow: 27 nTPM
- lung: 27 nTPM
- esophagus: 25 nTPM
Single-cell type
- tuft cells: 23 nCPM
- platelets: 16 nCPM
- neutrophils: 11 nCPM
- retinal horizontal cells: 10 nCPM
- rod photoreceptor cells: 9.7 nCPM
- distal convoluted tubule cells: 8.4 nCPM
Immune cell
- eosinophil: 60 nTPM
- neutrophil: 49 nTPM
- non-classical monocyte: 48 nTPM
- intermediate monocyte: 40 nTPM
- gdT-cell: 34 nTPM
- classical monocyte: 31 nTPM
Brain region
- medulla oblongata: 32 nTPM
- white matter: 30 nTPM
- pons: 29 nTPM
- cerebral cortex: 29 nTPM
- thalamus: 28 nTPM
- midbrain: 25 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IKBKG.
Disease | AllUniProt
Conditions IKBKG is implicated in, by any mechanism.
- Ectodermal dysplasia and immunodeficiency 1 (EDAID1) MIM:300291
- Immunodeficiency 33 (IMD33) MIM:300636
- Incontinentia pigmenti (IP) MIM:308300
- Autoinflammatory disease, systemic, X-linked (SAIDX) MIM:301081
Disease | GeneticClinVar
75 pathogenic / likely-pathogenic of 174 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Incontinentia pigmenti syndrome
- Ectodermal dysplasia and immunodeficiency 1
- Immunodeficiency 33
- ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED
- Autoinflammatory disease, X-linked
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.37
- gnomAD pLI
- 0.08
- gnomAD missense Z
- 0.03
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anoikis
- apoptotic process
- B cell homeostasis
- canonical NF-kappaB signal transduction
- defense response to bacterium
- DNA damage response
- establishment of vesicle localization
- immune response
- inflammatory response
- innate immune response
- negative regulation of canonical NF-kappaB signal transduction
- negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of gene expression
- positive regulation of macroautophagy
- positive regulation of NF-kappaB transcription factor activity
- positive regulation of T cell receptor signaling pathway
- positive regulation of transcription by RNA polymerase II
- positive regulation of ubiquitin-dependent protein catabolic process
- protein-containing complex assembly
- response to virus
- T cell receptor signaling pathway
Molecular functions
- identical protein binding
- K63-linked polyubiquitin modification-dependent protein binding
- linear polyubiquitin binding
- polyubiquitin modification-dependent protein binding
- protein domain specific binding
- protein heterodimerization activity
- protein homodimerization activity
- signaling adaptor activity
- transferrin receptor binding
- ubiquitin protein ligase binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IKBKG in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IKBKG as an antibody target. Whether an autoantibody or antibody against IKBKG could matter depends on whether native IKBKG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IKBKG is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IKBKG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...